T1	Intervention 18 66	granulocyte-macrophage colony-stimulating factor
T2	Intervention 279 287	(GM-CSF)
T3	Intervention 533 671	Zidovudine was discontinued in group A patients before instituting GM-CSF treatment and was restarted in a graduated fashion over 4 weeks.
T4	Intervention 672 775	Group B patients continued on full-dose (1,200 mg/d) zidovudine therapy while beginning GM-CSF therapy.
